A multiple-ascending dose study of pridopidine in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 28 May 2012
At a glance
- Drugs Pridopidine (Primary)
- Indications Huntington's disease
- Focus Adverse reactions; Therapeutic Use
- Acronyms MAD
- 28 May 2012 Status changed from recruiting to completed.
- 28 Sep 2011 New trial record